Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 22;11(4):395-399.
doi: 10.4274/jcrpe.galenos.2019.2018.0271. Epub 2019 May 23.

Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome

Małgorzata Wójcik  1   2 , Anna Ruszała  1   2 , Dominika Januś  1   2 , Jerzy B. Starzyk  1   2
Affiliations

Liver Biochemical Abnormalities in Adolescent Patients with Turner Syndrome

Małgorzata Wójcik et al. J Clin Res Pediatr Endocrinol. .

Abstract

Objective: Elevated liver function tests (LFTs) are common in adult Turner syndrome (TS) patients. Data regarding children and adolescents are lacking. To investigate the prevalence of abnormal LFTs in children and adolescents with TS during several years of observation; to evaluate the potential impact of increased body mass index (BMI) and sex hormone replacement therapy (HRT) on LFTs.

Methods: The analysis included 100 girls with TS, aged 4-16 years, all of whom were receiving recombinant human growth hormone therapy. A longitudinal study was conducted which included 81 patients.

Results: Mean BMI-standard deviation (SD) score of the subjects was 0.63 (SD: 1.53). Forty-four were being treated with HRT. Elevated LFTs were found in 34% of the patients overall (32% not receiving HRT vs 36% on HRT). The relative risk of increased LFTs was not higher in obese vs normal weight [odds ratio (OR): 0.2; 95% confidence interval (CI): 0.1-0.36, p=0.38 vs OR: 0.16; 95% CI: 0.08-0.3, p=0.1]. HRT did not increase the risk of abnormal LFTs activity (OR: 0.8; 95% CI: 0.5-1.2, p=0.37 vs OR: 0.7; 95% CI: 0.4-1.1, p=0.27). During the follow-up period (mean±SD=4.31±0.82 years), no patient developed overt liver disease. There was no significant increase nor decrease of abnormal LFT frequency in the subsequent years of follow up.

Conclusion: Constantly elevated LFTs in TS are common in children and adolescents with TS. However the causes and clinical significance remain unclear. This study suggests that obesity and HRT do not increase the risk of elevated LFTs.

Keywords: Turner syndrome; children; liver; estrogen.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Percentage of abnormal results of liver function tests during subsequent years of observation AST: aspartate aminotransferase, ALT: alanine aminotransferase
See this image and copyright information in PMC

References

    1. Koulouri O, Ostberg J, Conway GS. Liver dysfunction in Turner’s syndrome: prevalence, natural history and effect of exogenous estrogen. Clinical Endocrinol (Oxf) 2008;69:306–310. - PubMed
    1. Saenger P. Turner’s Syndrome. N Engl J Med. 1996;335:1749–1754. - PubMed
    1. Sylven L, Hagenfeldt K, Bröndum-Nielsen K, von Schoultz B. Middle-aged women with Turner’s syndrome. Medical status, hormonal treatment and social life. Acta Endocrinol (Copenh) 1991;125:359–365. - PubMed
    1. Larizza D, Locatelli M, Vitali L, Vigano C, Calcaterra V, Tinelli C, Sommaruga MG, Bozzini A, Campani R, Severi F. Serum liver enzymes in Turner syndrome. Eur J Pediatr. 2000;159:143–148. - PubMed
    1. Salerno M, Di Maio S, Gasparini N, Rizzo M, Ferri P, Vajro P. Liver abnormalities in Turner syndrome. Eur J Pediatr. 1999;158:618–623. - PubMed

MeSH terms